NSAID-enteropathy and intestinal microbes

NSAID–Gut Microbiota Interactions

(2020) Damian Maseda et al.   Frontiers in Pharmacology

Bifidobacterium breve Bif195 Protects Against Small-intestinal Damage Caused by Acetylsalicylic Acid in Healthy Volunteers

(2019) Brynjulf Mortensen et al.   GASTROENTEROLOGY

Mechanisms of Damage to the Gastrointestinal Tract From Nonsteroidal Anti-Inflammatory Drugs

(2018) Ingvar Bjarnason et al.   GASTROENTEROLOGY

Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria

(2018) Elizabeth A. Kennedy et al.   Frontiers in Physiology

Rifaximin Reduces the Number and Severity of Intestinal Lesions Associated With Use of Nonsteroidal Anti-Inflammatory Drugs in Humans

(2017) Carmelo Scarpignato et al.   GASTROENTEROLOGY

The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial

(2017) Zlatan Mujagic et al.   Scientific Reports

The influence of non-steroidal anti-inflammatory drugs on the gut microbiome

(2016) M.A.M. Rogers et al.   CLINICAL MICROBIOLOGY AND INFECTION

Comparative survival of commercial probiotic formulations: tests in biorelevant gastric fluids and real-time measurements using microcalorimetry

(2015) M. Fredua-Agyeman et al.   Beneficial Microbes

Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study

(2010) M. Montalto et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS